Bank of Montreal Portfolio holdings
Bank of Montreal (BMO), established in 1817 as Canada’s first chartered bank and headquartered in Montreal, Quebec (with key operations in Toronto), is a major North American financial institution offering personal and commercial banking, wealth management, and capital markets services. Managing hundreds of billions in assets, BMO serves over 13 million customers, with a strong U.S. presence through BMO Harris Bank, bolstered by its 1984 acquisition of Harris Bank and the 2022 purchase of Bank of the West, expanding its footprint to 32 states. Known for its longevity and stability, BMO has paid dividends since 1829, one of the longest streaks globally, and emphasizes digital innovation and sustainable finance under CEO Darryl White. With a global reach spanning North America, Europe, and Asia, BMO blends its historical roots with a modern focus on customer-centric growth.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AABA
Altaba Inc
AABA
|
+$616M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$239M |
| 3 |
DuPont de Nemours
DD
|
+$227M |
| 4 |
AbbVie
ABBV
|
+$223M |
| 5 |
General Motors
GM
|
+$177M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mondelez International
MDLZ
|
+$299M |
| 2 |
VanEck Gold Miners ETF
GDX
|
+$284M |
| 3 |
RAI
Reynolds American Inc
RAI
|
+$229M |
| 4 |
BP
BP
|
+$216M |
| 5 |
Air Products & Chemicals
APD
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 26.84% |
| 2 | Energy | 10.94% |
| 3 | Miscellaneous | 8.86% |
| 4 | Technology | 8.76% |
| 5 | Industrials | 8.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
GRCE
2576
Grace Therapeutics
GRCE
$42.9M
| $248K | ﹤0.01% |
3,646
| – | – |
2013 Q2
17 quarters
|
|
|
ARI
2577
Apollo Commercial Real Estate
ARI
$807M
| $247K | ﹤0.01% |
13,644
+3,586
| +36% | +$64.9K |
2013 Q2
17 quarters
|
|
2578
Ocular Therapeutix
OCUL
$1.6B
| $247K | ﹤0.01% |
40,084
+15,902
| +66% | +$102K |
2016 Q3
4 quarters
|
|
2579
Power Integrations
POWI
$2.88B
| $247K | ﹤0.01% |
6,756
| – | – |
2013 Q2
17 quarters
|
|
2580
Pacer Trendpilot US Large Cap ETF
PTLC
$3.33B
| $247K | ﹤0.01% |
9,092
| – | – |
2017 Q1
2 quarters
|
|
2581
Scholastic
SCHL
$647M
| $246K | ﹤0.01% |
6,628
| – | – |
2013 Q2
17 quarters
|
|
2582
PUT
Valvoline
VVV
$3.93B
| $246K | ﹤0.01% |
10,500
| – | – |
2016 Q4
3 quarters
|
|
2583
Axogen
AXGN
$2.34B
| $245K | ﹤0.01% |
12,649
-2,332
| -16% | -$39.2K |
2016 Q4
3 quarters
|
|
|
TECD
2584
DELISTED
Tech Data Corp
TECD
| $244K | ﹤0.01% |
2,755
-54,727
| -95% | -$5.4M |
2013 Q2
17 quarters
|
|
|
IMPV
2585
DELISTED
Imperva, Inc.
IMPV
| $244K | ﹤0.01% |
5,630
+3,354
| +147% | +$153K |
2013 Q2
17 quarters
|
|
|
EVG
2586
Eaton Vance Short Duration Diversified Income Fund
EVG
$134M
| $243K | ﹤0.01% |
17,076
+16,256
| +1,982% | +$232K |
2015 Q1
10 quarters
|
|
2587
Worthington Enterprises
WOR
$2.91B
| $243K | ﹤0.01% |
8,535
-3,469
| -29% | -$108K |
2013 Q2
17 quarters
|
|
2588
Northwest Bancshares
NWBI
$2.2B
| $242K | ﹤0.01% |
14,034
-2,412
| -15% | -$38.3K |
2013 Q2
17 quarters
|
|
|
TARO
2589
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $242K | ﹤0.01% |
2,147
+19
| +0.9% | +$2.07K |
2015 Q3
8 quarters
|
|
|
INOV
2590
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $242K | ﹤0.01% |
14,218
+212
| +2% | +$2.97K |
2016 Q1
6 quarters
|
|
2591
ProShares Ultra QQQ
QLD
$15.1B
| $241K | ﹤0.01% |
29,960
-6,520
| -18% | -$50.8K |
2015 Q4
7 quarters
|
|
2592
iShares 0-5 Year TIPS Bond ETF
STIP
$16.4B
| $241K | ﹤0.01% |
2,400
| – | – |
2013 Q2
17 quarters
|
|
2593
Johnson Outdoors
JOUT
$466M
| $240K | ﹤0.01% |
3,266
-1,492
| -31% | -$87K |
2016 Q3
4 quarters
|
|
|
PBPB
2594
DELISTED
Potbelly
PBPB
| $240K | ﹤0.01% |
19,365
+1,788
| +10% | +$20.8K |
2015 Q2
9 quarters
|
|
2595
Cheesecake Factory
CAKE
$5.37B
| $239K | ﹤0.01% |
5,656
+504
| +10% | +$22.4K |
2013 Q2
17 quarters
|
|
2596
Exponent
EXPO
$3.32B
| $239K | ﹤0.01% |
6,462
| – | – |
2013 Q2
17 quarters
|
|
2597
Invesco BuyBack Achievers ETF
PKW
$1.69B
| $239K | ﹤0.01% |
4,305
| – | – |
2013 Q2
17 quarters
|
|
|
ALDR
2598
DELISTED
Alder Biopharmaceuticals
ALDR
| $239K | ﹤0.01% |
19,505
+15,362
| +371% | +$160K |
2015 Q3
8 quarters
|
|
|
BEAT
2599
DELISTED
BioTelemetry, Inc.
BEAT
| $239K | ﹤0.01% |
7,231
-53,148
| -88% | -$1.84M |
2015 Q1
10 quarters
|
|
|
DCH
2600
Dauch Corp
DCH
$1.29B
| $237K | ﹤0.01% |
13,480
-100,506
| -88% | -$1.54M |
2013 Q2
17 quarters
|
|
Similar funds
Bank of Montreal's Q3 2017 Portfolio in Review
As of Q3 2017, Bank of Montreal held 4,520 positions worth $109B, up 4.7% from $104B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Bank of Montreal's Q3 2017 filing shows 258 new, 1,597 increased, 1,464 reduced and 295 closed positions. Its largest new stake was Kirkland Lake Gold Ltd Ordinary: 1,602,606 shares worth $20.7M. The largest sale was Mondelez International, an estimated $299M.
By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 26% a quarter earlier, followed by Energy and Miscellaneous.
- Bank of Montreal's largest Q3 2017 buy was Kirkland Lake Gold Ltd Ordinary: 1,602,606 shares worth $20.7M.
- Bank of Montreal added most to Altaba Inc in Q3 2017, an estimated $616M increase.
- Bank of Montreal's biggest Q3 2017 reduction was Mondelez International, cutting an estimated $299M.
- Bank of Montreal fully exited Reynolds American Inc in Q3 2017, selling an estimated $229M.
- Bank of Montreal's ten largest holdings make up 21% of its $109B portfolio in Q3 2017.
- Bank of Montreal opened 258 new positions and closed 295 in Q3 2017.
- Bank of Montreal's portfolio value rose 4.7% quarter-over-quarter to $109B.
Based on Bank of Montreal's 13F filing for Q3 2017, filed 16 Oct 2017.